PubRank

Ronald D Smith

Author PubWeight™ 30.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac. Nat Genet 2004 8.55
2 Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet 2009 5.23
3 Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int 2005 1.71
4 Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. J Hypertens 2002 1.49
5 TGF-beta signal transduction in chronic kidney disease. Front Biosci (Landmark Ed) 2009 1.41
6 Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trial. Circulation 2004 0.93
7 Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylases. Bioorg Med Chem 2006 0.92
8 Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension. Am J Hypertens 2002 0.90
9 Overland and near-surface transport of Cryptosporidium parvum from vegetated and nonvegetated surfaces. J Environ Qual 2004 0.88
10 Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. Clin Ther 2002 0.86
11 Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy. Am J Hypertens 2005 0.84
12 Noninvasive hemodynamic profiles in hypertensive subjects. Am J Hypertens 2005 0.82
13 Hemodynamic and hormonal patterns of untreated essential hypertension in men and women. Ther Adv Cardiovasc Dis 2013 0.82
14 Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension. Clin Ther 2003 0.81
15 Role of olmesartan in combination therapy in blood pressure control and vascular function. Vasc Health Risk Manag 2010 0.79
16 Losartan in patients with type 2 diabetes and proteinuria: observations from the RENAAL Study. Kidney Int Suppl 2002 0.78
17 Cost-effectiveness of impedance cardiography testing in uncontrolled hypertension. Am Heart Hosp J 2006 0.76
18 The role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertension. Ther Adv Cardiovasc Dis 2007 0.76
19 BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 6-HYDROXYDOPAMINE ADMINISTRATION INTO BRAIN. Biochem Pharmacol 1974 0.75
20 Amlodipine and losartan: reaction to comparison. J Clin Hypertens (Greenwich) 2003 0.75
21 Association between antihypertensive agent use and hospital admissions in a managed care population. Am J Med Sci 2004 0.75
22 Schwabe Symposia 2004-2006. Forward. Prev Vet Med 2008 0.75
23 Schwabe symposium 2007 on field disease investigation and population health-a symposium honoring the legacy of Dr. Clive C. Gay, Professor Emeritus from Washington State University. Prev Vet Med 2008 0.75
24 Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy. Hypertens Res 2009 0.75